comparemela.com

Latest Breaking News On - Fennec pharmaceuticals - Page 4 : comparemela.com

Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024 - Fennec Pharmaceuticals (NASDAQ:FENC)

Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024 - Fennec Pharmaceuticals (NASDAQ:FENC)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Lindsay-rocco
Robert-andrade
Fennec-pharmaceuticals-inc
Elixir-health-public-relations
Fennec-pharmaceuticals
Webcast-detail
Event-calendar
European-commission-marketing-authorization
Orphan-drug-exclusivity
Pediatric-use-marketing-authorization

Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024

Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Lindsay-rocco
Robert-andrade
Fennec-pharmaceuticals
Elixir-health-public-relations
Nasdaq
Fennec-pharmaceuticals-inc
Webcast-detail
Event-calendar
European-commission-marketing-authorization
Orphan-drug-exclusivity
Pediatric-use-marketing-authorization

Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024

Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Lindsay-rocco
Robert-andrade
Elixir-health-public-relations
Nasdaq
Fennec-pharmaceuticals
Fennec-pharmaceuticals-to-report-first-quarter
Fennec-pharmaceuticals-inc
Report-first-quarter
Webcast-detail
Event-calendar
European-commission-marketing-authorization
Orphan-drug-exclusivity

Adrian Haigh Sells 22,223 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) Stock

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) COO Adrian Haigh sold 22,223 shares of Fennec Pharmaceuticals stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $9.32, for a total transaction of $207,118.36. The transaction was disclosed in a legal filing with the SEC, which […]

United-states
Craig-hallum
Gendell-jeffrey
Adrian-haigh
Eudaimonia-advisors
Fennec-pharmaceuticals
Hartford-financial-management-inc
Capital-management
Worth-venture-partners
News-ratings-for-fennec-pharmaceuticals-daily
Fennec-pharmaceuticals-stock-performance
Institutional-investors-weigh-in-on-fennec-pharmaceuticals

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) COO Sells 22,222 Shares of Stock

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) COO Adrian Haigh sold 22,222 shares of the company’s stock in a transaction dated Friday, April 19th. The shares were sold at an average price of $9.34, for a total transaction of $207,553.48. The transaction was disclosed in a legal filing with the SEC, which can be […]

United-states
Craig-hallum
Adrian-haigh
Fennec-pharmaceuticals-inc
Hedge-funds-weigh-in-on-fennec-pharmaceuticals
Hartford-financial-management-inc
News-ratings-for-fennec-pharmaceuticals-daily
Fennec-pharmaceuticals-trading
Fennec-pharmaceuticals
Fennec-pharmaceuticals-company-profile
Eudaimonia-advisors
Tower-research-capital

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.